Xylem Inc. (NYSE:XYL) Expected to Post Quarterly Sales of $1.31 Billion

Equities analysts forecast that Xylem Inc. (NYSE:XYL) will post sales of $1.31 billion for the current quarter, according to Zacks. Five analysts have provided estimates for Xylem’s earnings, with the lowest sales estimate coming in at $1.30 billion and the highest estimate coming in at $1.31 billion. Xylem reported sales of $1.37 billion in the same quarter last year, which would suggest a negative year over year growth rate of 4.4%. The company is expected to issue its next quarterly earnings report before the market opens on Thursday, February 3rd.

According to Zacks, analysts expect that Xylem will report full year sales of $5.18 billion for the current fiscal year, with estimates ranging from $5.14 billion to $5.19 billion. For the next year, analysts forecast that the firm will report sales of $5.49 billion, with estimates ranging from $5.33 billion to $5.63 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that follow Xylem.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, November 2nd. The industrial products company reported $0.63 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.04. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.28 billion. Xylem had a return on equity of 15.97% and a net margin of 8.81%. During the same period in the previous year, the company posted $0.62 EPS.

XYL has been the subject of several research reports. Credit Suisse Group upped their target price on Xylem from $105.00 to $111.00 and gave the stock an “underperform” rating in a report on Wednesday, November 3rd. Rosenblatt Securities lowered shares of Xylem from a “buy” rating to a “hold” rating and dropped their price target for the company from $140.00 to $120.00 in a research report on Friday, October 1st. Royal Bank of Canada reduced their price objective on shares of Xylem from $140.00 to $136.00 and set an “outperform” rating for the company in a research report on Friday, October 1st. Boenning Scattergood restated a “neutral” rating on shares of Xylem in a research report on Tuesday, November 2nd. Finally, Mizuho initiated coverage on shares of Xylem in a research note on Thursday, December 16th. They set a “neutral” rating and a $115.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $122.30.

In other Xylem news, SVP Matthew Francis Pine sold 2,000 shares of the stock in a transaction on Wednesday, December 1st. The stock was sold at an average price of $121.32, for a total value of $242,640.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Colin R. Sabol sold 5,595 shares of Xylem stock in a transaction that occurred on Tuesday, October 19th. The shares were sold at an average price of $125.84, for a total value of $704,074.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 64,238 shares of company stock worth $8,470,296. Insiders own 0.90% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Moors & Cabot Inc. raised its holdings in shares of Xylem by 309.6% during the third quarter. Moors & Cabot Inc. now owns 28,000 shares of the industrial products company’s stock worth $28,000 after acquiring an additional 21,164 shares in the last quarter. Bell Investment Advisors Inc acquired a new stake in Xylem during the third quarter worth about $32,000. Massmutual Trust Co. FSB ADV raised its stake in shares of Xylem by 503.8% in the third quarter. Massmutual Trust Co. FSB ADV now owns 320 shares of the industrial products company’s stock valued at $40,000 after purchasing an additional 267 shares in the last quarter. Bedel Financial Consulting Inc. lifted its holdings in shares of Xylem by 99.5% during the 4th quarter. Bedel Financial Consulting Inc. now owns 401 shares of the industrial products company’s stock worth $48,000 after acquiring an additional 200 shares during the period. Finally, Compagnie Lombard Odier SCmA acquired a new position in Xylem during the third quarter worth $74,000. 83.84% of the stock is owned by institutional investors and hedge funds.

XYL traded down $3.13 during trading hours on Tuesday, hitting $111.29. The company’s stock had a trading volume of 73,323 shares, compared to its average volume of 802,061. Xylem has a 12 month low of $94.63 and a 12 month high of $138.78. The company has a current ratio of 2.33, a quick ratio of 1.81 and a debt-to-equity ratio of 0.79. The business’s 50-day moving average price is $122.02 and its 200-day moving average price is $125.57. The stock has a market cap of $20.07 billion, a price-to-earnings ratio of 43.21, a P/E/G ratio of 3.26 and a beta of 1.03.

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 21st. Investors of record on Tuesday, November 23rd were issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date was Monday, November 22nd. Xylem’s payout ratio is 43.92%.

Xylem Company Profile

Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.

Featured Story: How a Back-End Load Mutual Fund Works

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.